期刊文献+

辛伐他汀对骨质疏松大鼠血清骨钙素及骨密度的影响 被引量:3

Effect of simvastatin on serum osteocalcin and bone mineral denisity in osteoporosis rats
下载PDF
导出
摘要 目的:研究辛伐他汀对骨质疏松大鼠骨密度及血清骨钙素的影响,探讨其促进骨形成的作用。方法:36只雌性Wistar大鼠,随机分为4组。A组为假手术组,其余各组均行双侧卵巢切除术,术后1wk开始,A,B两组每只大鼠灌服生理盐水1.5mL·d-1,C组予辛伐他汀5mg·kg-1·d-1,D组予尼尔雌醇0.01mg·kg-1·d-1。10wk后处死大鼠,测量大鼠体重、股骨骨密度和血清骨钙素。结果:10wk后,B组大鼠体重高于A组,C,D组大鼠体重低于B组,均P<0.01。C,D组股骨骨密度(0.245±s0.007),(0.2430±0.0010)g·cm-2,高于B组(0.245±0.009)g·cm-2,血清骨钙素水平亦高于B组,均P<0.05,2组之间差异无显著意义(P>0.05)。结论:辛伐他汀能增加骨质疏松大鼠骨密度,提高骨钙素水平,促进新骨形成。 AIM: To study the effect of simvastatin on bone mineral density (BMD) and serum osteocalcin in osteoporosis rats together with its osteoblastic function. METHODS: Thirty-six Wistar female rats were randomly divided into four groups . The rats in group A were pseudo-ovariectomized and those in the other three groups were ova riectomized. One week after the operation, normal saline 1.5 mL was given to eac h rat in group A and B with simvastatin 5 mg·kg^(-1)·d^(-1) for rats in group C and nilestriol 0.01 mg·kg^(-1)·d^(-1) for rats in group D. All r ats were killed 10 wk later with measurements of weight, BMD and serum osteocalcin. RESULTS: After 10 wk, the weight in group A were lower than those in group B a nd so did the weight in groups C, D in comparing with group [JP2] B ((P<)(0.01)). The BMD of rats in group C, D ((0.245±)(s 0.00 7)[JP] ),((0.243)±(0.001))g·cm^(-2), were higher than that in group B ((0.245)±(0.009))g·cm^(-2) (P<(0.05)), including the same chang es of the levels of serum osteocalcin. There was no significant difference of BM D and serum osteocalcin between group C and D ((P>0.05)). CONCLUSION: Simvastatin can increase BMD and the level of serum osteocalcin, w ith stimulating the bone formation of osteoporosis rats.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2005年第7期547-549,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 骨质疏松 辛伐他汀 大鼠 骨钙素 骨密度 osteoporosis simvastatin rats osteocalcin bone mineral density
  • 相关文献

参考文献13

  • 1赵伟业,董碧蓉,欧雪梅,张玉芳,周焱.骨质疏松药物治疗的新进展及循证证据[J].中国骨质疏松杂志,2003,9(1):80-82. 被引量:54
  • 2MUNDY G, GARRETT R, HARRIS S, et al. Stimulation of bone formation in vitro and in rodents by statins [J]. Science, 1999,286(5446) :1946-1949.
  • 3OXLUND H, DALSTRA M, ANDREASSEN TT, et al. Statin given perorally to adult rats increases cancellous bone mass and compressive strength [J]. Calcif Tissue Int, 2001, 69(5):299-304.
  • 4PHILLIPS BW, BELMONTE N, VERNOCHET C, et al. Compactin enhances osteogenesis in murine embryonic stem cells [J]. Biochem Biophys Res Commun, 2001,284(2) :478-484.
  • 5叶伟胜,于顺禄,马宝通,李健兵.辛伐他汀间断给药对去卵巢大鼠成骨作用的初步实验观察[J].中华骨科杂志,2001,21(7):428-432. 被引量:32
  • 6EDWARDS C J, HART DJ, SPECTOR TD. Oral statins and increased bone mineral density in postmenopausal women [J]. Lancet, 2000,355(9222) :2218-2219.
  • 7姚朗,苏勇,蒋华良.他汀类调血脂药物的潜在新作用——抗骨质疏松[J].中国新药与临床杂志,2002,21(4):249-251. 被引量:24
  • 8GIAVARESI G, FINI M, GNUDI S, et al. The femoral distal epiphysis of ovariectomized rats as a site for studies on osteoporosis:structural and mechanical evaluations [J]. Clin Exp Rheumatol,2002,20 ( 2 ): 171-178.
  • 9OHNAKA K, SHIMODA S, NAWATA H, et al. Pitavastatin enhanced BMP-2 and osteocaclin expression by inhibition of Rho-associated kinase in human osteoblasts [J]. Biochem Biophys Res Commun ,2001,287 (2) :337-342.
  • 10SUGIYAMA M, KODAMA T, KONISHI K, et al. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells [J]. Biochem Biophys Res Common, 2000,271 ( 3 ) :688-692.

二级参考文献16

  • 1陈棣,叶伟胜.骨形态发生蛋白的成骨功能及临床应用[J].中华外科杂志,1996,34(10):602-605. 被引量:14
  • 2WANG GJ,CHUNG KC,SHEN WJ.Lipid clearing agents in steroid-induced osteoporosis[J].J Formosan Med Assoc,1995,94(10):589-592.
  • 3CUI Q,WANG GJ,SU CC,et al.The Otto Aufranc Award.Lovastatin prevents steroid induced adipogenesis and osteonecrosis[J].Clin Orthop,1997,(344):8-19.
  • 4MUNDY G,GARRETT R,HARRIS S,et al.Stimulation of bone formation in vitro and in rodents by statins[J].Science,1999,286(5446):1946-1949.
  • 5SUGIYAMA M,KODAMA T,KONISHI K,et al.Compactin and simvastatin,but not pravastatin,induce bone morphogenetic protein-2 in human osteosarcoma cells[J].Biochem Biophys Res Commun,2000,271(3):688-692.
  • 6MAEDA T,MATSUNUMA A,KAWANE T,et al.Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells[J].Biochem Biophys Res Commun,2001,280(3):874-877.
  • 7CHAN KA,ANDRADE SE,BOLES M,et al.Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women[J].Lancet,2000,359(9222):2185-2188.
  • 8MEIER CR,SCHLIENGER RG,KRAENZLIN ME,et al.HMG-CoA reductase inhibitors and the risk of fractures[J].JAMA,2000,283(24):3205-3210.
  • 9WANG PS,SOLOMON DH,MOGUN H,et al.HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients[J].JAMA,2000,283(24):3211-3216.
  • 10EDWARDS CJ,HART DJ,SPECTOR TD.Oral statins and increased bone-mineral density in postmenopausal women[J].Lancet,2000,355(9222):2218-2219.

共引文献108

同被引文献56

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部